References
Bennet MH, MacLennan KA, Vaughan Hudson G, Vaughan Hudson B (1991) Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. Ann Oncol Suppl 2:83–92
Hansmann ML, Stein H, Fellbaum C, Hui PK, Parwaresch MR, Lennert K (1989) Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol 20:1169–1975
Hartsell WF, Sarin PS, Recine DC, Kazlauskas LJ, Galinsky DL, Griem KL, Saxena VS, Murthy AK (1993) Long-term results of curative irradiation in pathologically staged IA and IIA Hodgkin disease. Radiology 186:565–568
Henry-Amar M, Somers R (1990) Survival outcome after Hodgkin's disease: a report from the International Data Base on Hodgkin's disease. Semin Oncol 18:29–33
Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS (1979) Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N Engl J Med 300:452–458
Leeuwen FE, Somers R, Taal BG, Heerde P, Coster B, Dozeman T, Huisman SJ, Hart AAM (1989) Increased risk of lung cancer, non-Hodgkin's lymphoma and leukemia following Hodgkin's disease. J Clin Oncol 7:1046–1058
Lennert K, Hansmann ML (1987) Progressive transformation of germinal centers: clinical significance and lymphocyte predominance Hodgkin's disease. The Kiel experience. Am J Surg Pathol 11:149
Mauch P, Tarbell N, Weinstein H, Silver B, Goffman T, Osteen R, Zajac A, Coleman CN, Canellos G, Rosenthal D (1988) Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol 6:1576–1583
Miettinen M, Franssila KO, Saxen E (1983) Hodgkin's disease, lymphocyte predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer 51:223–230
Pinkus GS, Said JW (1988) Hodgkin's disease lymphocyte predominance type, nodular, further evidence for a B-cell derivation. Am J Pathol 133:211–217
Poppema S, Kaiserling E, Lennert K (1979) Hodgkin's disease with lymphocyte predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres: a cytohistologic study. Histopathology 3:295–308
Rijswijk REN, Verbeek J, Haanen C, Dekker A, Daal WAJ, Peperzeel HA (1987) Major complications and causes of death in patients treated for Hodgkin's disease. J Clin Oncol 5:1624–1633
Sundeen JT, Cossman J, Jaffe ES (1988) Lymphocyte predominance Hodgkin's disease nodular subtype with coexistent “large cell lymphoma”. Am J Surg Pathol 12:599–606
Timens W, Visser L, Poppema S (1986) Nodular lymphocyte predominance type of Hodgkin's disease is a germinal centre lymphoma. Lab Invest 54:457–461
Tubiana M, Henry-Amar M, Carde P, Burgers JMV, Hayat M, Van der Shcueren E, Noordijk EM, Tanguy A, Meerwaldt JH, Thomas F, Pauw B, Mjonconduit M, Cosset JM, Somers R (1989) Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II Hodgkin's disease. The EORTC Lymphoma group controlled clinical trials: 1964–1987. Blood 73:47–56
Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA (1988) Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76–81
Author information
Authors and Affiliations
Additional information
Clinicopathologic conference held at the Leiden University Hospital. Members of the Department of Haematology and the Laboratory of Pathology of the Leiden University and Department of Internal Medicine Bronovo Hospital participated jointly in this conference
Rights and permissions
About this article
Cite this article
Hoogendoorn, M., van Krieken, J.H.J.M. & Bieger, R. A 37-year-old man with cholestatic jaundice and a prior history of Hodgkin's disease. Ann Hematol 70, 325–328 (1995). https://doi.org/10.1007/BF01696620
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01696620